Storms, W <br/><br/>
Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.  [electronic resource] 

 -  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology  Jan 2001 
 - 77-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-7894 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2222.2001.00969.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--therapeutic use<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Asthma--drug therapy<br/>Child<br/>Chronic Disease<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cyclopropanes<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Leukotriene Antagonists--therapeutic use<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Quinolines--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Sulfides<br/>Treatment Outcome